Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1
Jingnan Zhang(Shanghai University of Traditional Chinese Medicine), Lili Ji(Shanghai University of Traditional Chinese Medicine), Xiyu Mei(Hangzhou Hospital of Traditional Chinese Medicine), Manlin Li(State Administration of Traditional Chinese Medicine of the People's Republic of China), Zhenlin Huang(Hubei University of Chinese Medicine), Fan Yang(State Administration of Traditional Chinese Medicine of the People's Republic of China), Ze Zhang(Hebei Medical University), Changhong Wang(Shanghai University of Traditional Chinese Medicine), Zhengtao Wang(Guilin University of Technology), Qian Guo(Hebei Agricultural University), Bin Lü(Cedars-Sinai Medical Center), Zeqi Wu(State Administration of Traditional Chinese Medicine of the People's Republic of China)
Cited by 33
Related Papers
In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells
|Pharmacological Research|2006|165
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
|British Journal of Cancer|2019|124
Hypoglycemic effect and mechanism of a pectic polysaccharide with hexenuronic acid from the fruits of Ficus pumila L. in C57BL/KsJ db/db mice
|Carbohydrate Polymers|2017|120